Esperion Therapeutics (ESPR) Stock Chart & Stock Price History → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free ESPR Stock Alerts $2.08 +0.02 (+0.97%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Esperion Therapeutics Stock Price Performance5 Day Performance+9.47%1 Month Performance-33.33%3 Month Performance-5.02%6 Month Performance+101.94%Year-To-Date Performance-30.43%1 Year Performance+52.94% Receive ESPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ESPR Stock Chart for Saturday, May, 4, 2024 ESPR Chart by TradingView Esperion Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$2.06$2.08+0.97%$2.21$2.045.45 million shs$393.95 million05/02/2024$2.04$2.06+0.98%$2.12$2.032.87 million shs$390.16 million05/01/2024$1.97$2.04+3.55%$2.12$1.942.99 million shs$386.38 million04/30/2024$1.99$1.97-1.01%$2.04$1.942.34 million shs$373.12 million04/29/2024$1.90$1.99+4.74%$2.02$1.883.86 million shs$376.91 million04/26/2024$1.99$1.90-4.52%$2.01$1.884.20 million shs$359.86 million Get the Latest News and Ratings for ESPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$2.13$1.99-6.57%$2.10$1.955.06 million shs$376.91 million04/24/2024$2.09$2.13+1.91%$2.16$2.065.43 million shs$403.42 million04/23/2024$1.91$2.09+9.42%$2.13$1.934.94 million shs$395.85 million04/22/2024$1.95$1.91-2.05%$1.96$1.844.79 million shs$361.75 million04/19/2024$1.87$1.95+4.28%$1.97$1.717.35 million shs$369.33 million04/18/2024$1.84$1.87+1.63%$2.03$1.816.02 million shs$354.18 million04/17/2024$1.91$1.84-3.66%$1.96$1.813.71 million shs$348.50 million04/16/2024$1.94$1.91-1.29%$1.99$1.846.18 million shs$361.75 million04/15/2024$2.14$1.94-9.58%$2.13$1.936.82 million shs$366.49 million04/12/2024$2.31$2.14-7.36%$2.42$2.047.53 million shs$396.01 million04/11/2024$2.52$2.31-8.33%$2.54$2.258.80 million shs$427.47 million04/10/2024$2.79$2.52-9.68%$2.72$2.458.97 million shs$466.33 million04/09/2024$3.03$2.79-7.92%$3.17$2.765.75 million shs$516.29 million04/08/2024$3.24$3.03-6.48%$3.40$2.907.89 million shs$560.70 million04/05/2024$3.11$3.24+4.18%$3.40$3.0210.43 million shs$599.57 million04/04/2024$3.12$3.11-0.32%$3.40$3.0311.29 million shs$575.51 million04/03/2024$2.88$3.12+8.33%$3.33$2.9021.18 million shs$577.36 million04/02/2024$2.79$2.88+3.23%$3.01$2.696.30 million shs$532.94 million04/01/2024$2.68$2.79+4.10%$2.88$2.637.36 million shs$516.29 million03/29/2024$2.68$2.68$2.80$2.548.25 million shs$495.93 million03/28/2024$2.62$2.68+2.29%$2.80$2.548.18 million shs$495.93 million03/27/2024$2.70$2.62-2.96%$2.80$2.5211.94 million shs$484.83 million03/26/2024$2.62$2.70+3.05%$2.96$2.5614.73 million shs$499.64 million03/25/2024$2.29$2.62+14.41%$2.76$2.3127.39 million shs$484.84 million03/22/2024$2.11$2.29+8.53%$2.40$2.109.27 million shs$423.76 million03/21/2024$2.19$2.11-3.65%$2.24$2.064.54 million shs$390.46 million03/20/2024$2.08$2.19+5.29%$2.21$2.022.60 million shs$405.27 million03/19/2024$2.05$2.08+1.46%$2.21$2.013.95 million shs$384.90 million03/18/2024$2.07$2.05-0.97%$2.13$2.004.24 million shs$379.35 million03/15/2024$2.05$2.07+0.98%$2.15$1.9210.73 million shs$383.06 million03/14/2024$2.19$2.05-6.39%$2.25$2.015.61 million shs$379.35 million03/13/2024$2.05$2.19+6.83%$2.21$2.041.81 million shs$405.26 million03/12/2024$2.12$2.05-3.30%$2.15$2.042.42 million shs$379.35 million03/11/2024$2.19$2.12-3.20%$2.20$2.102.86 million shs$392.31 millionAutomatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free.03/08/2024$2.28$2.19-3.95%$2.30$2.183.18 million shs$405.26 million03/07/2024$2.46$2.28-7.32%$2.44$2.194.74 million shs$259.28 million03/06/2024$2.40$2.46+2.50%$2.52$2.372.12 million shs$279.75 million03/05/2024$2.44$2.40-1.64%$2.53$2.332.83 million shs$272.93 million03/04/2024$2.55$2.44-4.31%$2.61$2.363.23 million shs$277.48 million03/01/2024$2.51$2.55+1.59%$2.56$2.452.97 million shs$289.99 million02/29/2024$2.57$2.51-2.33%$2.74$2.493.27 million shs$285.44 million02/28/2024$2.90$2.57-11.38%$3.03$2.506.86 million shs$292.26 million02/27/2024$2.63$2.90+10.27%$3.00$2.399.89 million shs$329.79 million02/26/2024$2.61$2.63+0.77%$2.78$2.614.94 million shs$299.08 million02/23/2024$2.63$2.61-0.76%$2.68$2.503.51 million shs$296.81 million02/22/2024$2.61$2.63+0.77%$2.71$2.612.51 million shs$299.08 million02/21/2024$2.68$2.61-2.61%$2.69$2.524.62 million shs$296.80 million02/20/2024$2.69$2.68-0.37%$3.03$2.645.23 million shs$304.77 million02/19/2024$2.69$2.69$2.79$2.624.78 million shs$305.91 million02/16/2024$2.66$2.69+1.13%$2.79$2.624.77 million shs$305.90 million02/15/2024$2.61$2.66+1.92%$2.68$2.533.00 million shs$302.50 million02/14/2024$2.54$2.61+2.76%$2.67$2.502.80 million shs$296.81 million02/13/2024$2.60$2.54-2.31%$2.60$2.414.42 million shs$288.85 million02/12/2024$2.58$2.60+0.78%$2.75$2.563.53 million shs$295.67 million02/09/2024$2.58$2.58$2.75$2.563.84 million shs$293.40 million02/08/2024$2.63$2.58-1.90%$2.75$2.553.99 million shs$293.40 million02/07/2024$2.58$2.63+1.94%$2.74$2.544.67 million shs$299.08 million02/06/2024$2.38$2.58+8.40%$2.67$2.376.33 million shs$293.39 million02/05/2024$2.19$2.38+8.68%$2.41$2.156.80 million shs$270.65 million02/02/2024$2.07$2.19+5.80%$2.21$2.034.20 million shs$249.05 million Related Companies: Revance Therapeutics Stock Chart Amarin Stock Chart Lexicon Pharmaceuticals Stock Chart Nature's Sunshine Products Stock Chart Mereo BioPharma Group Stock Chart ADC Therapeutics Stock Chart Mersana Therapeutics Stock Chart Biomea Fusion Stock Chart Harrow Health Stock Chart Corbus Pharmaceuticals Stock Chart Receive ESPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESPR) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Esperion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.